NCAM1 and Miyoshi myopathy: In contrast, aberrant expression of adhesion molecule CD56 and CD117 (proto-oncogene c-kit; its high levels associated with a better OS in our patients with MM), related to an enhanced anchor through kit ligand expression on stromal cells in BM niches, is associated with a favorable outcome (41).